De-Bloat Balance
Natural health product licensed in Canada
- Other names
- De-Bloat Balance Capsules, Ginger, Fennel and Enzymes
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80148941
- Status
- Active licence
- Licence date
- 13 May 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 41.78 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 1.88 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. vulgare Source : Foeniculum vulgare subsp. vulgare var. vulgare - Seed Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 250 mg | 41.67 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma reesei - en entier | 2.5 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma reesei - en entier | 2.5 FCC HCU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1.05 FCC LU | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus niger - En entier | 1.7 Endo-PG | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus niger - En entier | 1.7 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Hypromellose, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps prevent nausea and vomiting associated with motion sickness, and/or seasickness. Digestive enzyme(s). Used in Herbal Medicine to help relieve digestive upset including bloating and flatulence. Used in Herbal Medicine to help relieve the pain associated with menstruation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80148941
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.